Related Experiment Video
Updated: Feb 24, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
[Sarcomas : Clinical introduction]
1Zentrum für Knochen- und Weichteiltumoren (SarKUM), LMU Klinikum, Medizinische Klinik III, Marchioninistr. 15, 81377, München, Deutschland. lars.lindner@med.uni-muenchen.de.
Abstract:
Sarcomas are malignant tumors of connective and supporting tissues characterized by substantial biological and clinical heterogeneity. Their optimal treatment requires specialized expertise, particularly in radiological diagnostics. The correct interpretation of imaging procedures represents the first crucial step in treatment planning. Radiologists play a key role by recognizing suspicious findings and initiating early referral to specialized sarcoma centers. Depending on the histological subtype, sarcomas require tailored imaging strategies. A notable example is whole-body magnetic resonance imaging (MRI) for the detection of osseous metastases in myxoid liposarcoma. The assessment of treatment response in the neoadjuvant setting also poses a particular challenge as it is not uncommon for treatment-related imaging changes to mimic tumor progression (pseudoprogression) and must be reliably distinguished from true progression. During follow-up an appropriate balance between oncologic safety, such as early detection of local recurrence or metastases, and minimizing cumulative radiation exposure must be achieved.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Sarcomere
Each...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

